Onconetix financials
$0.8200−26.13%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $17.1K | $21.5K | $303.6K | $303.7K | $106.5K | $101.6K | $712.0K | $406.9K | $704.8K | $700.4K | $58.5K |
| Gross profit | $4.3K | -$1.7K | $247.7K | $268.9K | $70.5K | $45.8K | $660.0K | $105.4K | $100.7K | $189.0K | -$1.1M |
| Gross margin | 25.1% | −7.7% | 81.6% | 88.6% | 66.2% | 45.1% | 92.7% | 25.9% | 14.3% | 27.0% | −1927.9% |
| Operating income | -$2.7M | -$10.2M | -$1.3M | -$2.1M | -$1.9M | -$12.6M | -$29.1M | -$2.6M | -$13.6M | -$11.1M | -$22.0M |
| Net income | -$2.9M | -$4.2M | $5.7M | -$8.8M | -$2.7M | -$9.7M | -$29.6M | -$3.8M | -$14.3M | -$11.1M | -$22.4M |
| Net margin | −16748.3% | −19643.4% | 1867.5% | −2892.7% | −2536.2% | −9560.1% | −4163.7% | −940.7% | −2029.8% | −1587.4% | −38229.5% |
| Diluted EPS | $-1.28 | $-67.10 | $123.73 | $-312.50 | $-237.91 | $-2272.50 | $-12106.67 | $-12454.00 | $-109579.50 | $-85340.00 | $-104990.74 |
| EBITDA | -$2.2M | -$2.1M | -$1.3M | -$2.1M | -$1.3M | -$1.6M | -$1.9M | -$2.4M | -$1.9M | -$3.4M | -$7.3M |
| Operating cash flow | -$1.9M | -$2.1M | -$3.1M | -$3.2M | -$1.4M | -$2.0M | -$917.6K | -$1.1M | -$3.2M | -$5.2M | -$4.3M |
| Free cash flow | -$1.9M | -$2.1M | -$3.1M | -$3.2M | -$1.4M | -$2.0M | -$921.5K | -$1.1M | -$3.2M | -$5.2M | -$10.4M |
| Diluted shares | 2.2M | 0.1M | 0.0M | 0.0M | 0.0M | 0.0M | 0.0M | 0.0M | 0.0M | 0.0M | 0.0M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $5.9M | $3.7M | $5.2M | $836.6K | $283.5K | $1.6M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $150.4K | $247.2K | $0.00 | $160.3K | $8.7M | $9.0M |
| Total assets | $16.4M | $14.8M | $24.9M | $19.7M | $19.1M | $18.8M |
| Total liabilities | $3.0M | $3.1M | $9.2M | $16.3M | $12.8M | $14.3M |
| Shareholders' equity | $13.5M | $11.7M | $15.8M | $3.4M | $6.4M | $4.0M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology